Jump to content

Pseudohypoxia

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Magtei (talk | contribs) at 20:17, 23 June 2014 (Moved to medical research). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Pseudohypoxia refers to increased cytosolic ratio of free NADH to NAD in cells.[1] Research has shown that declining levels of NAD+ during aging cause pseudohypoxia, and that raising nuclear NAD+ in old mice reverses pseudohypoxia and metabolic dysfunction, thus reversing the aging process.[2] It is expected that human NAD trials will begin in 2014.[3]

See also

References

  1. ^ [1] Diabetes Magazine: Hyperglycemic Pseudohypoxia and Diabetic Complications, March 12, 1993
  2. ^ [2] Declining NAD+ Induces a Pseudohypoxic State Disrupting Nuclear-Mitochondrial Communication during Aging, Cell, Dec 2013
  3. ^ [3] Guardian Newspaper - Online, Dec 2013